Michael Koslowski
Algemeen Directeur bij Kling Biotherapeutics BV
Oorsprong van het eerstegraads netwerk van Michael Koslowski
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Kling Biotherapeutics BV
Kling Biotherapeutics BV BiotechnologyHealth Technology Kling Biotherapeutics BV is a clinical-stage biotechnology company based in the Netherlands. The Dutch company has developed a pipeline that evaluates B cells in individuals with remarkable responses to cancer and infectious diseases. Kling Biotherapeutics' proprietary B cell immortalization platform enables rapid functional screening of antibodies, leading to the identification of several antibodies targeting novel epitopes and cancer-associated antigens with unique post-translational modifications. Michael Koslowski has been the CEO of the company since 2022.
1
| Holding Company | Biotechnology | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Michael Koslowski via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
SCHRÖDINGER, INC. | Packaged Software | Director/Board Member | |
REGULUS THERAPEUTICS INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
California Institute for Biomedical Research
California Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services The California Institute for Biomedical Research provides biomedical research services. The non-profit company is based in La Jolla, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
ENYO Pharma SA
ENYO Pharma SA BiotechnologyHealth Technology ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France. | Biotechnology | Director/Board Member | |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
CureVac SE
CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Biotechnology | Director/Board Member | |
The Johns Hopkins University School of Medicine | College/University | Doctorate Degree | |
Time Bioventures
Time Bioventures Investment ManagersFinance Time Bioventures (Time Bioventures) is a venture capital firm founded in 2019 by D.A. Wallach. The firm is headquartered in Los Angeles, California. | Investment Managers | Private Equity Investor | |
University of Delaware | College/University | Undergraduate Degree | |
CUREVAC N.V. | Pharmaceuticals: Major | Director/Board Member | |
Pfizer GmbH | Chief Tech/Sci/R&D Officer | ||
University of Pittsburgh Medical Center
University of Pittsburgh Medical Center Medical/Nursing ServicesHealth Services University of Pittsburgh Medical Center is a non-profit organization, which engages in the provision of hospital health programs and services. It operates through the following business units: Provider Services, Insurance Services, UPMC International, and UPMC Enterprises. It also develops programs in transplantation, cancer, neurosurgery, psychiatry, orthopedics, and sports medicine. The company was founded in 1893 and is headquartered in Pittsburgh, PA. | Medical/Nursing Services | Corporate Officer/Principal |
Statistieken
Internationaal
Verenigde Staten | 9 |
Duitsland | 4 |
Frankrijk | 2 |
Sectoraal
Health Technology | 6 |
Consumer Services | 3 |
Technology Services | 2 |
Commercial Services | 2 |
Finance | 2 |
Operationeel
Director/Board Member | 4 |
Corporate Officer/Principal | 4 |
Independent Dir/Board Member | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Doctorate Degree | 1 |
Sterkste connecties
Insiders | |
---|---|
Timothy M. Wright | 13 |
- Beurs
- Insiders
- Michael Koslowski
- Bedrijfsconnecties